🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The success of the U.S. vaccination program against SARS-Cov-2 is shown by ...
Status
Terminated
Location
Griffin Hospital
Start Date
2021-10-15
Trial ID
NCT05081271
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Status
Completed
Location
National Centre for Infectious Diseases (NCID)
Start Date
2021-10-12
Trial ID
NCT05142319
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, dose-escalation s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05609045
Treatments Being Tested
A phase 1/2, open-label clinical trial in individuals, 18 years of age and ...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2021-05-28
Trial ID
NCT04889209
Treatments Being Tested
This is randomized, placebo-controlled, observer-blinded, multi-center stud...
Status
Unknown
Location
Korea University Ansan Hospital
Start Date
2022-01-24
Trial ID
NCT05175950
Primary#Objectives #Immunogenicity:To demonstrate the non-inferiority of bi...
Status
Unknown
Location
Savannakhét Provincial hospital
Start Date
2022-10-19
Trial ID
NCT05686161
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel cor...
Status
Completed
Location
Victoria Biomedical Research Institute
Start Date
2022-05-18
Trial ID
NCT07408297
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Completed
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2022-01-22
Trial ID
NCT05197153
Treatments Being Tested
Phase 2 clinical trial in adults previously vaccinated against SARS-CoV-2 i...
Status
Completed
Location
Universidad del Desarrollo - Clínica Alemana
Start Date
2022-11-28
Trial ID
NCT05593042
Treatments Being Tested